Seguir
Patricia Ashton-Prolla
Patricia Ashton-Prolla
Universidade Federal do Rio Grande do Sul, Hospital de Clinicas de Porto Alegre
Dirección de correo verificada de hcpa.edu.br
Título
Citado por
Citado por
Año
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
MIW Achatz, M Olivier, F Le Calvez, G Martel-Planche, A Lopes, BM Rossi, ...
Cancer letters 245 (1-2), 96-102, 2007
2262007
Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.
P Ashton-Prolla, B Tong, J Shabbeer, KH Astrin, CM Eng, RJ Desnick
Journal of investigative medicine: the official publication of the American …, 2000
1742000
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect
S Garritano, F Gemignani, EI Palmero, M Olivier, G Martel‐Planche, ...
Human mutation 31 (2), 143-150, 2010
1622010
Thalidomide, a current teratogen in South America
EE Castilla, P Ashton‐Prolla, E Barreda‐Mejia, D Brunoni, DP Cavalcanti, ...
Teratology 54 (6), 273-277, 1996
1491996
TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
C Rosset, CBO Netto, P Ashton-Prolla
Genetics and molecular biology 40, 69-79, 2017
1382017
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
EI Palmero, L Schüler-Faccini, M Caleffi, MIW Achatz, M Olivier, ...
Cancer letters 261 (1), 21-25, 2008
1332008
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome
EI Palmero, MIW Achatz, P Ashton-Prolla, M Olivier, P Hainaut
Current opinion in oncology 22 (1), 64-69, 2010
1262010
Genomic rearrangements in BRCA1 and BRCA2: A literature review
IP Ewald, PLI Ribeiro, EI Palmero, SL Cossio, R Giugliani, ...
Genetics and Molecular Biology 32, 437-446, 2009
1262009
An alternative protocol for DNA extraction from formalin fixed and paraffin wax embedded tissue
R Coura, JC Prolla, L Meurer, P Ashton-Prolla
Journal of Clinical Pathology 58 (8), 894-895, 2005
1162005
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
P Ashton-Prolla, J Giacomazzi, AV Schmidt, FL Roth, EI Palmero, ...
BMC cancer 9, 1-9, 2009
1042009
Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study
L Schüler, A Pastuszak, MTV Sanseverino, IM Orioliz, D Brunoni, ...
Reproductive Toxicology 13 (2), 147-151, 1999
1011999
Conocimiento del cáncer de mama y cáncer de mama hereditario en el personal de enfermería de un hospital público
CMD Prolla, PS Silva, CBO Netto, JR Goldim, P Ashton-Prolla
Revista latino-americana de enfermagem 23, 90-97, 2015
932015
Impact of β1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy
A Biolo, N Clausell, KG Santos, R Salvaro, P Ashton-Prolla, A Borges, ...
The American journal of cardiology 102 (6), 726-732, 2008
872008
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis
V Marcel, EI Palmero, P Falagan-Lotsch, G Martel-Planche, ...
Journal of medical genetics 46 (11), 766-772, 2009
822009
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
B Leroy, ML Ballinger, F Baran-Marszak, GL Bond, A Braithwaite, ...
Cancer research 77 (6), 1250-1260, 2017
812017
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
MIW Achatz, P Hainaut, P Ashton-Prolla
The lancet oncology 10 (9), 920-925, 2009
802009
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
P Izetti, A Hautefeuille, AL Abujamra, CB de Farias, J Giacomazzi, ...
Investigational new drugs 32, 783-794, 2014
772014
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
EI Palmero, DM Carraro, B Alemar, MAM Moreira, A Ribeiro-dos-Santos, ...
Scientific reports 8 (1), 9188, 2018
752018
Prevalence of the TP53 p. R337H mutation in breast cancer patients in Brazil
J Giacomazzi, MS Graudenz, CABT Osorio, P Koehler-Santos, EI Palmero, ...
PloS one 9 (6), e99893, 2014
712014
miRNA-21 and miRNA-34a are potential minimally invasive biomarkers for the diagnosis of pancreatic ductal adenocarcinoma
B Alemar, P Izetti, C Gregorio, GS Macedo, MAA Castro, AB Osvaldt, ...
Pancreas 45 (1), 84-92, 2016
702016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20